Anomalous Oscillation Modes of Superfluid Pendant Droplets.

Droplets should exhibit various dynamical phenomena when adhered to a surface; not all of them are realized in classical fluids. Visualization of superfluid ^{4}He pendant droplets revealed that the droplets were horizontally translated on a flat surface, bouncing off at the corner, known as the Noether mode that reflects the translation symmetry. The droplets exhibited another mode in vertical oscillations with high amplitude that included oscillation of the droplet edge.

A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan.

We evaluated the teratogenic risk associated with exposure to cefditoren pivoxil during the first trimester of pregnancy using the integrated databases of the Toranomon Hospital and the National Center for Child Health and Development. Among 13 599 registered individuals, the analysis included 285 subjects who had taken cefditoren pivoxil during the first trimester of pregnancy. The rates of stillbirth, miscarriage, and elective terminations were 0.

Acid-base responsive molecular switching of a [2]rotaxane incorporating two different stations in an axle component.

Interlocked compounds such as rotaxanes and catenanes exhibit unique kinetic properties in response to external chemical or physical stimuli and are therefore expected to be applied to molecular machines and molecular sensors. To develop a novel rotaxane for this application, an isophthalamide macrocycle and a neutral phenanthroline axle were used. Stable pseudorotaxanes are known to be formed using hydrogen bonds and π-π interactions.

Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy.

To assess the risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol during pregnancy, we conducted a prospective cohort study using counseling data for drug use during pregnancy provided by the Japan Drug Information Institute in Pregnancy and Toranomon Hospital. Counseling information, including drug usage and participants' demographic information, was collected between April 1988 and December 2017. Pregnancy outcome data, including major birth defects, were obtained using a questionnaire administered 1 month after delivery.